Ireland-Based Felixvet Plans Briarcliff, Missouri, North American Headquarters
07/14/2023
The new office will serve as the center to support commercial and regulatory operations throughout the U.S. and Canada.
"We are confident that Felixvet is poised to become one of the leading companion animal generic drug companies globally," said Vince Palasota, president of North America at Felix. "With our extensive pipeline, quick response capabilities and deep understanding of ANADA and brand competition strategies, we believe the veterinarian and marketing partners will recognize the significant value-added benefits we bring to the table."
Felix develops bio-equivalent generic pharmaceutical products for companion animals upon patent expiry. The company’s initial focus is to market and distribute these products in the U.S., upon approval by the Food and Drug Administration.
“We are proud to welcome Felixvet, a business committed to advancing animal health through high-quality pharmaceuticals, to the Kansas City region,” noted Kimberly Young, president of the KC Animal Health Corridor. “Here, Felix will enjoy proximity to many of their industry clients who call the KC Animal Health Corridor home, as well as abundant access to distribution resources and a robust animal health industry network."
Project Announcements
France-Based Sartorius Stedim Plans Marlborough, Massachusetts, Bioprocess Operations
12/10/2024
357 Brewers Expands Myrtle Beach, South Carolina, Operations
12/05/2024
Koch Foods Expands Morton, Mississippi, Operations
12/04/2024
Irving Tissue Expands Macon, Georgia, Production Operations
12/03/2024
General Mills Expands Hannibal, Missouri, Production Operations
12/03/2024
US Foods Expands Buda, Texas, Distribution Operations
12/03/2024
Most Read
-
How Automation Is Actually Closing the Labor Gap
Q4 2024
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
The Role of Rail in Industrial Development
Q4 2024
-
Hydrogen Industry in Canada: A Global Leader in the Clean Energy Revolution
Q3 2024
-
Which AI Tools Work for Job Recruiters?
Q3 2024
-
Permitted Power Capacity Foreshadows Health of Regional Economies
Q3 2024
-
Navigating Non-Disclosure Agreements in Site Selection
Q3 2024